No matches

Type 2 Inflammation

ADVENT at ERS 2025

Join leading pulmonologists across asthma and COPD for educational symposia at the ERS congress in Amsterdam, Netherlands.

MD, PhD, FERS

Klaus Rabe +7 more

See post-event materials

Past event

27September2025

Symposium Details

September 28

Type 2 Severe Asthma "Unplugged": Reducing Mucus to Improve Long-Term Patient Outcomes

Join leading pulmonologists Drs. Njira Lugogo, Simon Couillard, and Mario Castro, as they explore the role of type 2 inflammation in the pathogenesis of mucus plugging in the airways, the burden of excess mucus in patients with moderate-to-severe asthma, and how reducing airway mucus may lead to improved long-term patient outcomes.

See On-Demand materials

September 29

Less Flare, More Function: Recognizing the Full Spectrum of COPD Patient Outcomes

Join leading pulmonologists Drs. Nicola Hanania, Surya Bhatt, and Celeste Porsbjerg, along with Sanofi and Regeneron, as they explore the burden of COPD in patients with underlying type 2 inflammation, delve into the mechanistic pathways driven by key cytokines contributing to lung function decline and reduced quality of life, and examine the latest Phase 3 clinical trial data to identify which patients may benefit most from emerging biologic therapies.

September 29

The Knowns and Unknowns in the COPD Landscape - Concepts in Disease Stability

Join Sanofi and Regeneron with leading pulmonologists Prof. Dave Singh and Prof. Klaus Rabe as they examine the clinical relevance of exacerbations, lung function, symptoms, quality of life, and comorbidities in COPD. Faculty will also discuss the evolving concept of disease stability and what that could mean for treatment planning and the future of COPD care.

Speakers

Pulmonology

MD, PhD, FERS

Klaus Rabe

Professor of Pulmonary Medicine | University of Kiel; Director of the Department of Pneumology | LungClinic Grosshansdorf, Kiel, Germany

Pulmonology

FBPhS, MD, FERS

Dave Singh

Respiratory Physician, Professor of Clinical Pharmacology and Respiratory Medicine |University of Manchester, Manchester, United Kingdom

Pulmonology

MD, PhD

Celeste Porsbjerg

Professor of Severe Asthma, Bispebjerg Hospital Copenhagen, Denmark

Pulmonology

MD, MS, FCCP, FACP, FRCP, FERS

Nicola A. Hanania

Professor of Medicine, Section of Pulmonary and Critical Care Medicine; Director, Airways Clinical Research Center, Baylor College of Medicine; Chief, Section of Pulmonary, Critical Care and Sleep Medicine, Ben Taub Hospital

Pulmonology

MD, MPH

Mario Castro

Chief, Pulmonary, Critical Care and Sleep Medicine; Vice Chair for Clinical and Translational Research, University of Kansas School of Medicine

Pulmonology

Surya Bhatt

Dr. Surya Bhatt serves as the Medical Director of the UAB Pulmonary Function and Exercise Physiology Lab, a state-of-the-art lab for pulmonary physiology testing, and as Medical Director of Pulmonary Rehabilitatio

Pulmonology

Njira Lugogo

Dr. Lugogo is a Professor of Medicine in the Division of Pulmonary, Critical Care Medicine and is the Director of the Michigan Medicine Asthma Program. She is also the Program Director of INHALE, a statewide collaborative quality improvement program that focuses on improving the care of patients with asthma and COPD in Michigan.

Pulmonology

MD, MSc

Simon Couillard

Professor Couillard is a respirologist and the Québec Lung Association Chair of Respiratory Research at the Université de Sherbrooke, Canada. He leads a team investigating ways to use biomarkers to predict and prevent asthma attacks and improve asthma management.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region